Pfarr, Nicole 
; Kirchner, Martina ; Lehmann, Ulrich ; Leichsenring, Jonas ; Merkelbach‐Bruse, Sabine ; Glade, Julia ; Hummel, Michael ; Stögbauer, Fabian ; Lehmann, Annika ; Trautmann, Marcel ; Kumbrink, Jörg ; Jung, Andreas ; Dietmaier, Wolfgang ; Endris, Volker ; Kazdal, Daniel ; Evert, Matthias ; Horst, David ; Kreipe, Hans ; Kirchner, Thomas ; Wardelmann, Eva ; Lassen, Ulrik ; Büttner, Reinhard ; Weichert, Wilko ; Dietel, Manfred ; Schirmacher, Peter ; Stenzinger, Albrecht
; Kirchner, Martina ; Lehmann, Ulrich ; Leichsenring, Jonas ; Merkelbach‐Bruse, Sabine ; Glade, Julia ; Hummel, Michael ; Stögbauer, Fabian ; Lehmann, Annika ; Trautmann, Marcel ; Kumbrink, Jörg ; Jung, Andreas ; Dietmaier, Wolfgang ; Endris, Volker ; Kazdal, Daniel ; Evert, Matthias ; Horst, David ; Kreipe, Hans ; Kirchner, Thomas ; Wardelmann, Eva ; Lassen, Ulrik ; Büttner, Reinhard ; Weichert, Wilko ; Dietel, Manfred ; Schirmacher, Peter ; Stenzinger, Albrecht 
Abstract
NTRK fusions involving three neurotrophic tyrosine receptor kinase genes NTRK1, NTRK2, and NTRK3 and a variety of fusion partners were identified as oncogenic drivers across many cancer types. Drugs that target the chimeric protein product require the identification of the underlying gene fusion. This advocates the diagnostic use of molecular assays ranging from fluorescence in situ hybridization ...
Owner only: item control page
Altmetric